Heron Therapeutics (HRTX) Q4 2023 Earnings

12MarConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.35
-0.26
-0.16
-0.07

Details

Expected EPS
-0.153833
Actual EPS
-0.07
Surprise EPS
0.08
Surprise Percent
+54.5%

Description

Heron Therapeutics (HRTX) has reported earnings of -0.07 per share for Q4 2023.

0 Comments

Share your thoughts